Adventist Health Enhances Online Access for Both New and Existing Patients with Kyruus and Cerner Collaboration by Kyruus, on Sep 15, 2020 9:00:00 AM California-Based Health System is First to Offer Kyruus ProviderMatch® Integrated with the Cerner Consumer FrameworkTM...
Saniona successfully raises USD 65 million (approximately SEK 567 million) in a directed issue of shares NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE...
ESCAPE BIO CLOSES $73 MILLION IN CROSSOVER FINANCING TO ADVANCE CLINICAL DEVELOPMENT OF PRECISION NEUROLOGY MEDICINES FOR GENETIC NEURODEGENERATION – ESCAPE BIO SOUTH SAN FRANCISCO, September 14, 2020 — ESCAPE Bio, a clinical stage company developing novel, precisely...
ReViral Announces FDA Fast Track Designation Granted to Sisunatovir For The Treatment of Serious Respiratory Syncytial Virus Infection London, UK, and Research Triangle Park, NC, August 4, 2020 – ReViral Ltd., a clinical-stage biopharmaceutical company focused on...
Approval based on Phase III ETHOS trial which showed a statistically significant reduction in the rate of exacerbations compared with dual-combination therapies AstraZeneca’s Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) has been approved in the...
Glympse Bio Announces $46.7 Million Series B Financing Proceeds Support PMA-Enabling Study of Glympse Technology in NASH Patients CAMBRIDGE, Mass., July 15, 2020 – Glympse Bio (Glympse), a biotechnology company advancing the way diseases are understood, tracked, and...
Recent Comments